Phase 3 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The cancer has come back in or near the area where it was originally treated (called a locoregional recurrence) after major surgery to remove it
- The surgeon was unable to remove all of the cancer during surgery (known as a positive resection margin, or R1/R2 result)
- The cancer has come back in an area that was not covered by previous radiation treatment given after surgery
- The cancer has come back after chemotherapy that was given following surgery
- No treatment has been received for the cancer since it came back
- People aged between 16 and 70 years old
- People who are generally able to carry out most daily activities (a performance score above 70 on the Karnofsky scale — confirm with trial site if unsure what this means)
- No history of allergic reactions to medications
- The liver and kidneys are working well enough (confirm with trial site for specific thresholds)
- A white blood cell count above 4.0 × 10⁹/L, which is a measure of immune system health
Who may not be able to join:
- People who are older than 70 or younger than 16 years of age
- People who are currently pregnant or breastfeeding
- People who have a history of allergic reactions to medications
- People who do not wish to give their informed consent to participate
- People whose liver or kidney function is not at a sufficient level, or whose blood count results are abnormal
- People with serious heart or blood vessel conditions, active infections, active stomach or intestinal ulcers, diabetes with poorly controlled blood sugar levels, or mental health disorders
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-13621018159
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1-, 2-, 3-year overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.